|
SPAST expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.453600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.296200E-02 |
| Normal-vs-Stage2 |
4.683600E-01 |
| Normal-vs-Stage3 |
2.635800E-01 |
| Normal-vs-Stage4 |
4.787200E-01 |
| Stage1-vs-Stage2 |
4.439000E-01 |
| Stage1-vs-Stage3 |
4.426200E-01 |
| Stage1-vs-Stage4 |
5.682300E-03 |
| Stage2-vs-Stage3 |
8.615000E-01 |
| Stage2-vs-Stage4 |
2.221600E-01 |
| Stage3-vs-Stage4 |
9.521700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.091700E-02 |
| Normal-vs-AfricanAmerican |
4.613600E-02 |
| Normal-vs-Asian |
5.845000E-01 |
| Caucasian-vs-AfricanAmerican |
2.504600E-01 |
| Caucasian-vs-Asian |
4.495400E-01 |
| AfricanAmerican-vs-Asian |
1.049150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.835800E-02 |
| Normal-vs-Female |
1.069960E-01 |
| Male-vs-Female |
5.288400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.799100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.622400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.652600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.244400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.603670E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.617700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.707600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.905200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.279600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.263400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.876500E-02 |
| Classical-VS-Follicular |
2.773800E-01 |
| Classical-VS-Other |
3.640200E-01 |
| Classical-VS-Normal |
1.165640E-02 |
| Tall-VS-Follicular |
4.928600E-01 |
| Tall-VS-Other |
8.895600E-01 |
| Tall-VS-Normal |
9.455000E-01 |
| Follicular-VS-Other |
7.012400E-01 |
| Follicular-VS-Normal |
4.554000E-01 |
| Other-VS-Normal |
8.352600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.577020E-01 |
| Normal-vs-N1 |
5.636400E-01 |
| N0-vs-N1 |
7.777500E-02 |
|
|
